Michael J. Lane
Net Worth

Last updated:

What is Michael J. Lane net worth?

The estimated net worth of Mr. Michael J. Lane is at least $31,863,138 as of 7 Nov 2023. He owns shares worth $2,568,013 as insider, has earned $21,525,125 from insider trading and has received compensation worth at least $7,770,000 in IDEXX Laboratories, Inc..

What is the salary of Michael J. Lane?

Mr. Michael J. Lane salary is $1,110,000 per year as Executive Vice President and GM of Reference Laboratories & Information Technology in IDEXX Laboratories, Inc..

How old is Michael J. Lane?

Mr. Michael J. Lane is 57 years old, born in 1968.

What stocks does Michael J. Lane currently own?

As insider, Mr. Michael J. Lane owns shares in one company:

Company Title Shares Price per share Total value
IDEXX Laboratories, Inc. (IDXX) Executive Vice President and GM of Reference Laboratories & Information Technology 4,033 $636.75 $2,568,013

What does IDEXX Laboratories, Inc. do?

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDXX logo
IDXX
IDEXX Laboratories, Inc.
$636.75

Michael J. Lane insider trading

IDEXX Laboratories, Inc.

Mr. Michael J. Lane has made 10 insider trades between 2018-2023, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 17,961 units of IDXX stock on 5 Aug 2019. As of 7 Nov 2023 he still owns at least 4,033 units of IDXX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 462 $67.85 $31,347
Option
Common Stock 560 $178.26 $99,826
Option
Incentive Stock Option (right-to-buy) 1,728 $129.24 $223,322
Option
Common Stock 706 $141.6 $99,970
Option
Incentive Stock Option (right-to-buy) 8,947 $159.93 $1,430,894
Sale
Common Stock 16,027 $510 $8,173,770
Option
Common Stock 1,512 $141.6 $214,099
Option
Common Stock 7,080 $206.94 $1,465,135
Option
Incentive Stock Option (right-to-buy) 7,080 $206.94 $1,465,135
Option
Common Stock 7,435 $178.26 $1,325,363
Sale
Common Stock 1,000 $484 $484,000
Option
Common Stock 181 N/A N/A
Option
Common Stock 161 N/A N/A
Option
Restricted Stock Unit 204 N/A N/A
Option
Restricted Stock Unit 161 N/A N/A
Option
Restricted Stock Unit 173 N/A N/A
Option
Restricted Stock Unit 181 N/A N/A
Option
Restricted Stock Unit 196 N/A N/A
Option
Common Stock 204 N/A N/A
Option
Common Stock 196 N/A N/A
Option
Common Stock 173 N/A N/A
Option
Common Stock 161 N/A N/A
Option
Restricted Stock Unit 161 N/A N/A
Option
Common Stock 181 N/A N/A
Option
Common Stock 173 N/A N/A
Option
Restricted Stock Unit 181 N/A N/A
Option
Restricted Stock Unit 196 N/A N/A
Option
Restricted Stock Unit 211 N/A N/A
Option
Common Stock 211 N/A N/A
Option
Common Stock 196 N/A N/A
Option
Restricted Stock Unit 173 N/A N/A
Option
Non-Qualified Stock Option (right-to-buy) 5,527 $104.73 $578,815
Option
Common Stock 6,999 $92.43 $646,939
Option
Incentive Stock Option (right-to-buy) 1,472 $67.85 $99,875
Sale
Common Stock 6,999 $690.96 $4,836,015
Sale
Common Stock 850 $545 $463,250
Option
Non-Qualified Stock Option (right-to-buy) 1,968 $67.85 $133,529
Option
Incentive Stock Option (right-to-buy) 883 $73.7 $65,073
Option
Common Stock 2,851 $71.75 $204,551
Sale
Common Stock 1,304 $443 $577,671
Option
Common Stock 1,000 N/A N/A
Option
Restricted Stock Unit 1,000 N/A N/A
Option
Incentive Stock Option (right-to-buy) 2,651 $69.8 $185,032
Option
Non-Qualified Stock Option (right-to-buy) 12,763 $116.81 $1,490,884
Sale
Common Stock 17,961 $264.29 $4,746,913
Option
Common Stock 15,414 $96.66 $1,489,963
Sale
Common Stock 1,812 $245.41 $444,683
Option
Incentive Stock Option (right-to-buy) 3,322 $45.84 $152,280
Sale
Common Stock 736 $211.58 $155,723
Option
Common Stock 3,322 $45.84 $152,280
Sale
Common Stock 971 $208 $201,968
Option
Restricted Stock Unit 1,060 N/A N/A
Option
Restricted Stock Unit 1,966 N/A N/A
Option
Common Stock 1,060 N/A N/A
Option
Non-Qualified Stock Option (right-to-buy) 8,366 $206.94 $1,731,260
Option
Incentive Stock Option (right-to-buy) 483 N/A N/A
Option
Non-Qualified Stock Option (right-to-buy) 5,838 $69.8 $407,475
Option
Common Stock 5,838 $69.8 $407,475
Sale
Common Stock 5,912 $243.76 $1,441,133

IDEXX Laboratories key executives

IDEXX Laboratories, Inc. executives and other stock owners filed with the SEC: